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10 Abstract
11 Background Metabolomics is a powerful tool for investigating the association between nutrition and health status. Although
12 urine is commonly employed for studying the metabolism and transformation of food components, the use of blood samples
13 could be preferable to gain new insights into the bioavailability of diet-derived compounds and their involvement in health.
14 However, the chemical complexity of blood samples hinders the analysis of this biological fluid considerably, which makes
15 the development of novel and comprehensive analytical methods mandatory.
16 Methods In this work, we optimized a multi-targeted metabolomics platform for the quantitative and simultaneous analysis
17 of 450 food-derived metabolites by ultra-high performance liquid chromatography coupled to tandem mass spectrometry. To
18 handle the chemical complexity of blood samples, three complementary extraction methods were assayed and compared in
19 terms of recovery, sensitivity, precision and matrix effects with the aim of maximizing metabolomics coverage: protein
20 precipitation, reversed solid-phase extraction, and hybrid protein precipitation with solid-phase extraction-mediated phos-
21 pholipid removal.
22 Results After careful optimization of the extraction conditions, protein precipitation enabled the most efficient and high-
23 throughput extraction of the food metabolome in plasma, although solid-phase extraction-based protocols provided com-
24 plementary performance for the analysis of specific polyphenol classes. The developed method yielded accurate recovery
25 rates with negligible matrix effects, and good linearity, as well as high sensitivity and precision for most of the analyzed
26 metabolites.
27 Conclusions The multi-targeted metabolomics platform optimized in this work enables the simultaneous detection and
28 quantitation of 450 dietary metabolites in short-run times using small volumes of biological sample, which facilitates its
29 application to epidemiological studies.
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31 Metabolomics is nowadays one of the most powerful tools
32 in nutrition research since metabolites can be used as direct
33 and objective indicators of food intake, and they can also
34 provide valuable information about multiple biological and
35 lifestyle factors (e.g., genetic background, disease, micro-
36 biota, and xenobiotics) [1]. The potential applications of
37 metabolomics in nutrition (i.e., nutrimetabolomics) and
38 biomedical research include (i) the discovery of food intake
39 biomarkers for dietary assessment, (ii) the identification of
40 metabolic pathways altered because of dietary interventions,
41 and (iii) the investigation of the association between nutri-
42 tion and health status. The measurement of dietary bio-
43 markers has demonstrated excellent performance in
44 increasing the efficacy of dietary assessment, complement-
45 ing traditional self-reported surveys [2]. Furthermore,
46 metabolomics approaches are also of particular interest for
47 studying diseases closely linked to nutritional and lifestyle
48 factors, such as obesity and metabolic disorders. Indeed,
49 numerous metabolomics-based works have been published
50 in recent years investigating the interaction between diet,
51 genes, and microbiota in obesity and related disorders, as
52 well as developing precision nutrition recommendations
53 [3, 4]. However, recent research emphasizes the need for
54 novel tools for accurate measurement of food-derived
55 metabolites to gain deeper insights into the association
56 between nutrition and health in nutritional epidemiology,
57 particularly in a quantitative manner to allow for cross-
58 cohort comparisons [5–7].Q1Q234
59 The food metabolome is highly heterogeneous and
60 complex, comprising nutrients, secondary bioactive meta-
61 bolites, additives, and cooking-derived compounds [8].
62 After ingestion, these dietary components are extensively
63 transformed by phase I/II reactions and/or gut microbiota,
64 and are then rapidly excreted mostly in urine, but also in
65 other matrixes such us feces and bile. Due to water reab-
66 sorption in the kidney, the concentration of food metabolites
67 is usually higher in urine than in other biological samples,
68 clearly reflecting the ADME (Absorption, Distribution,
69 Metabolism, and Excretion) process [1]. For this reason,
70 and because large volumes can be collected using non-
71 invasive procedures, urine is normally the preferred biofluid
72 in nutrimetabolomics for studying the metabolism and
73 transformation of food components [1, 5]. On the other
74 hand, plasma/serum samples are more likely to provide
75 deeper insights into the bioavailability of nutrients and
76 diet × health interactions, since blood is a rich source of
77 metabolically active compounds that are in transit from one
78 organ to another, whereas the major function of urine is
79 only to dispose of unwanted compounds in the body [9].
80 Furthermore, the advantages of blood samples compared
81 with urine include: (i) lower inter- and intra-individual
82variability [1]; (ii) the possibility of detecting lipophilic
83biomarkers, which usually have longer half-lives [10]; and
84(iii) the more common availability of blood samples in
85large-cohort studies.
86The aim of this work was to optimize a targeted meta-
87bolomics method for the analysis of diet-related metabolites
88in blood samples. Previous publications on this topic
89usually employ an enzymatic hydrolysis step of phase II
90metabolites [11–13], which significantly simplifies the
91metabolome complexity and consequently the analytical
92procedure, but hinders the performance of comprehensive
93metabolomics because optimal hydrolysis conditions
94depend on specific metabolite classes. Recent studies
95described the optimization of targeted methods focused on
96the analysis of specific biomarker classes [14–16]. How-
97ever, the great complexity of the food metabolome makes
98mandatory the development of novel methods to increase
99the analytical comprehensiveness, allowing the simulta-
100neous analysis of as many metabolites as possible in a
101single run to minimize costs and the consumption of valu-
102able biological samples. Furthermore, high-throughput
103nutrimetabolomics approaches are also needed to explore
104the inter-individual variability in response to food con-
105sumption [17]. In this context, we have recently developed a
106metabolomics platform for the simultaneous quantitation of
107350 food intake biomarkers in urine samples [18]. None-
108theless, the application of these methodologies to blood is
109hindered considerably by the chemical complexity of this
110biological fluid, characterized by high contents of proteins
111and lipids, and lower concentrations of dietary metabolites
112compared with urine. To overcome this hurdle, a multi-
113targeted metabolomics method has been optimized in the
114present work for the detection and quantification of a wide
115range of food-related metabolites and microbiota derivatives
116in plasma, paying special attention to the optimization of
117efficient extraction protocols.
118Materials and methods
119Extraction of plasma samples
120For the optimization of the extraction conditions, blank
121plasma samples were collected from healthy volunteers after
122one week of a low-polyphenol diet, as previously described
123[19]. Furthermore, to look for potential food-derived
124metabolites for which standards are currently not avail-
125able, healthy volunteers were asked to follow acute dietary
126interventions with several foods (orange, grapefruit, apple,
127banana, red wine, beer, green tea, coffee, soy sprouts,
128walnuts, wholegrain rye, and oat), as described elsewhere
129[18]. These foods were consumed at dinner, and then first-










130 morning-void urine samples were collected (i.e., 8–12 h
131 after intake).
132 For all the tested extraction methods, plasma samples
133 (100 μL) were first thawed in an ice bath and spiked with
134 10 μL of a set of isotopically labeled internal standards
135 (ferulic acid-1,2,3-13C3, L-phenylalanine-
15N) dissolved in
136 ultrapure water at 1 mg L−1. For validation purposes, some
137 samples were also spiked with known concentrations of 256
138 food-derived metabolites for which pure standards were
139 available (see Supplementary Information). After the
140 extraction as described below for the three compared
141 methods, extracts were taken to dryness using a MaxiVac β
142 vacuum concentrator (Daejeon, South Korea), and recon-
143 stituted with 100 μL of water:acetonitrile (80:20, v/v) con-
144 taining 0.1% formic acid and internal standards for
145 quantification (taxifolin and caffeine-13C3, 100 μg L
−1).
146 Protein precipitation (PPT)
147 Plasma samples were mixed with 500 μL of cold acetonitrile
148 (−20 °C) containing 1.5 M formic acid and 10 mM
149 ammonium formate in an Eppendorf tube, and then vigor-
150 ously shaken using a vortex mixer. Samples were kept at
151 −20 °C for 10 min to promote PPT, then centrifuged at
152 10,000 × g for 10 min at 4 °C, and supernatants were finally
153 transferred to new tubes.
154 Hybrid PPT and solid-phase extraction (SPE)-mediated
155 phospholipid removal (Ostro®)
156 Following a modification of the method previously devel-
157 oped by Tulipani et al. [20], plasma samples were pipetted
158 into Ostro® 96-well plates (Waters, Milford, MA, USA) and
159 mixed with 500 μL of cold acetonitrile (−20 °C) containing
160 1.5 M formic acid and 10 mM ammonium formate. Subse-
161 quently, plates were vortexed and kept at −20 °C for 10 min
162 to promote in-well PPT. A Waters Positive Pressure-96
163 Processor was then employed to collect deproteinized
164 extracts in a 96-well collection plate. Finally, 500 μL of cold
165 acetonitrile (−20 °C) containing 0.5% ammonia (v/v) were
166 added to wells containing the protein precipitates to perform
167 a second extraction. After vortex shaking, positive pressure
168 was again applied to collect the second extract in the same
169 collection plate.
170 SPE (Oasis® HLB)
171 SPE was performed using Oasis® HLB 96-well plates, filled
172 with 30 mg of sorbent (Waters, Milford, MA, USA),
173 according to the method described by González-Domínguez
174 et al. with some modifications [18]. Briefly, the sorbent was
175 first conditioned with 1 mL of methanol and 1 mL of water
176 containing 1.5 M formic acid and 10 mM ammonium
177formate. Then, a mixture of the plasma sample with 900 μL
178of 2% H3PO4 in water (v/v) was loaded onto the pre-
179conditioned plate. Plates were washed with 1 mL of water
180containing 1.5 M formic acid and 10 mM ammonium for-
181mate. Finally, retained metabolites were eluted with 1.5 mL
182of methanol containing 1.5 M formic acid and 10 mM
183ammonium formate.
184Quantitative metabolomic fingerprinting by UHPLC-
185MS/MS
186Metabolomic analyses were conducted following the
187methodology developed by González-Domínguez et al.
188with modifications (Table S1) [18]. Analyses were per-
189formed on an Agilent 1290 Infinity UHPLC system (Santa
190Clara, CA, USA) coupled to a Sciex QTRAP 6500 mass
191spectrometer equipped with an Ion-Drive Turbo V ion
192source (Framingham, MA, USA). Chromatographic
193separations were performed on a Luna Omega Polar C18
194column, 100 mm × 2.1 mm (i.d. 1.6 μm), equipped with a
195fully porous polar C18 security guard cartridge from Phe-
196nomenex (Torrance, CA, USA). Water containing 0.1%
197formic acid and 10 mM ammonium formate and acetonitrile
198were used as aqueous (A) and organic (B) mobile phases in
199the negative ion mode, applying the following gradient
200program: 0–8 min, 5–20% B; 8–10 min, 20–100% B;
20110–12 min, 100% B; 12–12.1 min, 100-5% B; 12.1–14 min,
2025% B. Under positive ionization, water and acetonitrile,
203both containing 0.5% formic acid, were used as mobile
204phases: 0–5 min, 5–50% B; 5–5.1 min, 50–100% B;
2055.1–7 min, 100% B; 7–7.1 min, 100–5% B; 7.1–9 min, 5%
206B. Other chromatographic conditions were as follows: col-
207umn temperature, 40 °C; autosampler temperature, 4 °C;
208injection volume, 2 μL; flow rate, 0.5 mLmin−1. On the
209other hand, MS detection was performed by using the
210scheduled multiple reaction monitoring (sMRM) mode,
211under positive and negative ionization in separate runs,
212applying the following parameters: ion spray voltage,
213+4500/−3500 V; source temperature, 600 °C; curtain gas,
21430 psi; ion source gas 1 and gas 2, 50 psi each; collision-
215activated dissociation gas, 3 psi; entrance potential, (+/−)
21610 V. The MRM transitions were optimized by infusing
217individual solutions of commercial standards dissolved in
218mobile phase (proportion A:B 1:1 (v/v), 500 μg L−1) into
219the mass spectrometer using a syringe pump at a flow rate of
2205 μL min−1. The optimization of MRM conditions for those
221metabolites for which authentic standards were not avail-
222able was performed as previously described [18]. Briefly,
223samples collected after acute dietary interventions were
224subjected to product ion scan experiments (MS2) by using
225predicted nominal masses of expected metabolites, and
226those peaks showing neutral losses of 176 Da (i.e., glucur-
227onide conjugates) or 80 Da (i.e., sulfate conjugates) were










Table 1 Summary of metabolites included in the multi-targeted metabolomics fingerprinting platform.
Class Metabolites Food
Phenolic acids
Hydroxybenzoic acids (N= 52) Hydroxy/dihydroxy-benzoic, hippuric, (iso)
vanillic, syringic, gallic acids
Plant foods (fruits, vegetables, grains,
legumes, nuts)
Hydroxyphenylacetic acids (N= 16) Hydroxy/dihydroxy-phenylacetic,
homovanillic acids






Others (N= 35) Dihydroxyphenylpentanoic acid, pyrogallol,
syringol, catechol, hydroxybenzaldehydes
Flavonoids
Flavan-3-ols (N= 31) Catechin, epicatechin Tea, berry fruits, cocoa, apple
Flavanones (N= 10) Naringenin, hesperetin Citrus fruits
Isoflavones (N= 23) Daidzein, genistein, equol, biochanin A,
formononetin
Soy, legumes
Flavones (N= 5) Apigenin, luteolin Plant foods (fruits, vegetables, grains,
legumes, nuts)
Flavonols (N= 10) Quercetin, kaempferol, isorhamnetin Plant foods (fruits, vegetables, grains,
legumes, nuts)
Anthocyanins (N= 6) Cyanidin, malvidin, delphinidin, pelargonidin,
peonidin, petunidin
Berry fruits
Dihydrochalcones (N= 2) Phloretin Apple
Phenylethanoids (N= 13) Hydroxytyrosol Olive oil
Stilbenes (N= 20) Resveratrol Grapes, red wine
Coumarins (N= 7) Bergaptol, umbelliferone Fruits (Rutaceae), vegetables (Umbelliferae)
Curcuminoids (N= 2) Curcumin Curcuma




Prenylflavonoids (N= 1) Isoxanthohumol Beer
Other phytochemicals
Benzoxazinoids (N= 20) BOA, HBOA, DIBOA, HMBOA, DIMBOA Wholegrain wheat and rye
Hydroxycinnamic amides (N= 6) Avenanthramides Wholegrain oat
Steroid glycosides (N= 2) Avenacosides Wholegrain oat
Glucosinolates (N= 5) Sulforaphane Cruciferous vegetables (cabbage, broccoli)
Organosulfurated metabolites (N=
2)
Allylcysteine Allium vegetables (garlic, onion)
Glycoalkaloids (N= 4) Solanidine, tomatidine Solanaceae vegetables (potato, tomato)






Flavan-3-ol rich foods (tea, berry fruits,
cocoa, apple)
Urolithins (N= 9) Urolithins A, B, C Ellagitannin rich foods (berry fruits, nuts,
pomegranate)
Enterolignans (N= 6) Enterolactone, enterodiol Fiber rich foods
Hydroxylated phenylacetamides (N
= 9)
Hydroxyphenylacetamide Wholegrain wheat and rye
Phenoxazinones (N= 4) APO, AMPO, AAPO, AAMPO Wholegrain wheat and rye
Miscellaneous










228 subjected to MS3 fragmentation of the corresponding
229 aglycone. Then, MRM transitions and fragmentation para-
230 meters were experimentally optimized to obtain the highest
231 sensitivity. Optimized MRM transitions, declustering
232 potentials (DPs), collision energies (CEs), cell exit poten-
233 tials (CXPs), retention times (RTs), and RT windows are
234 listed in Table S1. Analyst 1.6.2 and Sciex OS-Q software
235 (ABSciex, Framingham, MA, USA) were used for data
236 acquisition and data processing, respectively.
237 Method validation
238 The optimized methodology was validated according to the
239 guidelines defined by the US Food and Drug Administra-
240 tion (FDA) for bioanalytical method validation [21]. Cali-
241 bration curves were prepared in both solvent and blank
242 plasma at 12 concentration levels ranging from 0.1 to
243 2000 μg L−1 by diluting individual stock solutions of stan-
244 dards (1000 mg L−1). Recoveries were determined in
245 plasma samples spiked at three concentration levels (5, 100,
246 500 μg L−1), which were analyzed in triplicate. Matrix
247 effects (MEs) were measured by comparing the analyte
248 response of standards dissolved in solvent and plasma at the
249 same concentration level (5, 100, 500 μg L−1). Intra-day and
250 inter-day precisions were evaluated by analyzing spiked
251 plasma samples at three concentration levels (5, 100,
252 500 μg L−1) five times within the same day and on three
253 consecutive days, respectively. The limits of quantification
254 (LOQs) were estimated in spiked plasma as the lowest
255 concentration that gives an average signal-to-noise (S/N)
256 ratio above 10, with accuracies varying from 80% to 120%
257 of the theoretical value. LOQs were calculated by
258subtracting the analyte response observed in non-spiked
259blank plasma.
260Validation of putative biomarkers
261Ten healthy volunteers (40.4 ± 4.1 years, 6/4 males/females)
262were enrolled in a 1-month intervention trial with a Medi-
263terranean diet supplemented with red wine (270 mL day−1).
264Fasting plasma samples were collected at baseline (free-
265living) and at the end of the intervention period, and were
266stored at −80 °C until analysis. The study was performed in
267accordance with the principles contained in the Declaration
268of Helsinki. The Bioethical Committee of the Hospital
269Virgen de la Victoria (Málaga, Spain) approved the study
270protocol, and all the participants provided written informed
271consent. The study was registered under ClinicalTrials.gov
272as NCT03101436. The metabolomics dataset obtained after
273analyzing plasma samples were subjected to t-test statistical




278In the present work, a novel multi-targeted metabolomics
279fingerprinting approach was optimized for the analysis of
280plasmatic food-derived metabolites and microbiota deriva-
281tives, by using a modification of the recently published
282Quantitative Dietary Fingerprinting (QDF) approach [18].
283The coverage of the new method was significantly enlarged
Table 1 (continued)
Class Metabolites Food
Methylxanthines (N= 16) Methylxanthines, methyluric acids Coffee, tea, cocoa
Artificial sweeteners (N= 4) Acesulfame K, sucralose, saccharin and cyclamate Sweetened beverages
Fatty acids (N= 4) Pentadecanoic, margaric, eicosapentaenoic,
docosahexaenoic acids
Dairy products (odd chain fatty acids), fish
(polyunsaturated fatty acids)
Maillard reaction products (N= 5) Furan derivatives Heat-treated foods (coffee, cocoa)
Diketopiperazines (N= 2) Cyclo(leucyl-prolyl), cyclo(prolyl-valyl) Heat-treated foods (coffee, cocoa)
Polycyclic compounds (N= 2) 1-hydroxypyrene glucuronide, PhIP-G Heat-treated (meat, fish)
Betaines (N= 13) Betainized amino acids, trigonelline, arsenobetaine,
ergothioneine, hypaphorine
Wholegrains (amino acid betaines), citrus fruits
(proline betaine), coffee (trigonelline), mushrooms
(ergothioneine), fish (arsenobetaine), legumes
(trigonelline, hypaphorine)
Histidine derivatives (N= 4) 1-methylhistidine, 3-methylhistidine, carnosine,
anserine
Animal foods
Salsolinol (N= 2) Derivatives of salsolinol Banana
Alcohol and tobacco consumption
(N= 6)
Ethyl-glucuronide/sulfate, derivatives of nicotine Alcohol and tobacco
Others (N= 4) Creatinine, TMAO, tartaric acid, pinitol, Various










284 by including some novel dietary metabolites: fatty acids
285 (dairy products, fish), benzoxazinoids and microbiota deri-
286 vatives (wheat and rye), avenanthramides and avenacosides
287 (oat), lignans (fiber-rich foods), and some others. The
288 optimized method thus enables the simultaneous detection
289 and quantitation of 450 food-derived metabolites in very
290 short run times (9 min+ 14 min, under positive and nega-
291 tive ionization, respectively), as summarized in Table 1.
292 From this metabolomic library, pure standards were avail-
293 able for 256 metabolites (level I identification according to
294 the Metabolomics Standards Initiative guidelines). The rest
295 of the metabolites included in the method were identified in
296 samples collected after dietary interventions (level II iden-
297 tification), accounting for 43.2% of the total number of
298 metabolites assayed, which evidences the difficulty of per-
299 forming comprehensive nutrimetabolomics because of the
300 lack of commercial standards. The MRM parameters of
301 these latter metabolites were optimized as previously
302 described [18].
303 To create this method, we not only considered already
304 validated food intake biomarkers but also a comprehensive
305 number of food-related metabolites and microbiota deriva-
306 tives, which could be of great interest for different purposes.
307 First, it should be noted that, to date, research on food
308 intake biomarkers has been mainly accomplished by using
309 non-targeted metabolomics approaches, which show a great
310 potential in “discovery studies” but present serious analy-
311 tical limitations for validation purposes (e.g., a lack of
312 absolute quantitation, problems associated with robustness/
313 reproducibility). Thus, we strongly believe that the metho-
314 dology described in the present work could have great
315 potential to perform more robust validation studies,
316 according to the guidelines recently described [7]. Fur-
317 thermore, although many of the metabolites covered in this
318 methodology probably lack the required specificity to be
319 considered as food intake biomarkers (e.g., most phenolic
320 acids can be indicative of the consumption of plant-derived
321 foods, but cannot serve as biomarkers of specific foods),
322 they can provide additional and complementary information
323 about metabolism and biotransformation processes, e.g., in
324 nutrikinetic studies.
325 Optimization of the plasma extraction method
326 Three extraction methods commonly employed in nutri-
327 metabolomics were optimized and compared for the
328 simultaneous recovery of food-related metabolites listed in
329 Table 1: (i) protein precipitation, (ii) hybrid protein pre-
330 cipitation and SPE-mediated phospholipid removal
331 (Ostro®), and (iii) reversed-phase SPE (Oasis® HLB).
332 For protein precipitation (PPT), 1% formic acid in acet-
333 onitrile was first tested as an extractant, and provided good
334 recoveries for simple phenolic acids but failed to extract
335most phase II metabolites and flavonoids. Various organic
336solvents were then compared with maximize the extraction
337efficiency, but in general, acetonitrile provided better
338recoveries and more efficient protein removal. Two-step
339extraction procedures, based on solvent-mediated PPT and
340subsequent extraction of the protein pellet, were also
341assayed by combining solvents with different polarities
342(e.g., methanol, acetone, ethyl acetate). The application of a
343second extraction step with methanol slightly increased the
344extraction recovery for some specific polyphenol classes
345(e.g., anthocyanins), but the resulting extracts were more
346prone to be contaminated with particles in suspension from
347the protein precipitate. As an alternative, different additives
348were tested with the aim of reducing interactions with
349proteins and improving the extraction process. The acidity
350of the precipitation solvent was found to be critical, espe-
351cially for flavonoid aglycones and phase II metabolites.
352Additionally, the use of ammonium formate also improved
353the extraction of anionic compounds (e.g., sulfate deriva-
354tives), as previously described [18]. Therefore, the use of
355acetonitrile containing 1.5 M formic acid and 10 mM
356ammonium formate was demonstrated to provide the most
357efficient extraction of the 450 food-related metabolites here
358analyzed by means of PPT, with extraction recoveries in the
359range of 80–120% for the majority of metabolites monitored
360(Table S2). However, worse results were observed for some
361flavonoids, especially in their aglycone form, due to their
362chromatographic co-elution with phospholipid species
363(experimentally checked), which may interact with minor
364metabolites and cause ion suppression [22]. For this reason,
365a second extraction protocol based on hybrid PPT and SPE-
366mediated phospholipid removal was also tested. A slight
367modification of the method developed by Tulipani et al.
368[20], employing acetonitrile with 1.5M formic acid and
36910 mM ammonium formate for in-plate PPT, provided
370excellent recoveries for most of the metabolites monitored
371by UHPLC-MS/MS, but the extraction of flavan-3-ol
372metabolites was considerably worse than with simple
373PPT. According to Khymenets et al. [23], the application of
374a second extraction step with basic acetonitrile significantly
375improved the elution of this polyphenol class, but the
376extraction efficiency was still lower than that obtained by
377PPT. Finally, we also tested the potential of reversed-phase
378SPE for the extraction of plasma samples, as the gold-
379standard technique for the cleanup of complex biological
380samples and the extraction of polyphenols [24]. Taking as a
381reference the SPE methodology previously optimized by
382González-Domínguez et al. [18], but taking into con-
383sideration the improvements found in this study to minimize
384protein interactions by adding 1.5 M formic acid and
38510 mM ammonium formate to extraction solvents, an effi-
386cient recovery of the majority of polyphenol classes was
387achieved.










388 Another crucial factor to be considered was the minimum
389 volume of plasma needed to obtain reliable results. Similar
390 extraction recoveries and precision were found by using
391 volumes in the range of 20–200 μL, but sensitivity was
392 significantly reduced while decreasing the initial sample
393 volume due to dilution effects. Furthermore, the suitability
394 of applying a pre-concentration step was also assessed to
395 increase the method sensitivity. For this purpose, extracts
396 obtained by using the three extraction protocols previously
397 described were taken to dryness using a vacuum con-
398 centrator before UHPLC-MS/MS analysis. As a compro-
399 mise between the volume of sample to be employed and the
400 method sensitivity and robustness, the best results were
401 obtained by extracting 100 μL of plasma/serum and using a
402 reconstitution volume of 100 μL.
403 Validation of the method
404 The quantitative multi-targeted platform developed in this
405 work was validated in terms of linearity, extraction effi-
406 ciency, matrix effects, sensitivity, and both intra- and inter-
407 day precision for each one of the three extraction methods
408 optimized, as summarized in Table 2 (detailed information
409 can be found in Supplemental Tables S2–S5).
410 As shown in Fig. 1, the three protocols provided excel-
411 lent extraction efficiencies for most phenolic acids and
412 related phase II metabolites, but significant differences were
413 observed concerning flavonoid derivatives. In general,
414 Ostro® plates were best suited to the extraction of flavonoid
415 aglycones, while HLB provided the lowest recoveries for
416 these dietary markers. On the other hand, excellent recovery
417 yields were obtained for phase II derivatives of flavonoids
418 regardless of the extraction method, with the exception of
419 some diglucuronide and sulfoglucuronide species of iso-
420 flavones, for which the use of HLB provided the best
421 results. A different behavior was particularly observed for
422 flavan-3-ols and some microbiota-derived hydroxyphenyl-
423 valerolactones, which were only successfully extracted by
424 PPT. This could be due to the occurrence of strong inter-
425 actions between these metabolites and the SPE sorbents, as
426 previously described [25]. Furthermore, it is also note-
427 worthy that maximum recovery rates for anthocyanin spe-
428 cies were around 80%, in line with previous works
429 reporting the difficulty of extracting and analyzing these
430 flavonoids because of their susceptibility to undergo
431 degradation and structural rearrangements [26]. Another
432 notorious difference among the three optimized protocols is
433 the inability of the HLB method to recover polar metabo-
434 lites not retained in the SPE sorbent (Table S2). Similarly,
435 HLB also provided lower extraction recoveries for some
436 medium-polarity metabolites, such as hydroxytyrosol deri-
437 vatives and glucosinolates. Finally, it should also be noted
438 that some metabolites (e.g., benzoic acid) were not
439quantifiable by using SPE-based procedures (i.e., Ostro®
440and HLB) due to the release of some interfering compounds
441(checked in blank extracts).
442Calibration curves, prepared both in solvent and in
443plasma matrix, showed high linearity over 3–4 orders of
444magnitude, within the concentration range 0.1–2000 μg L−1.
445The MS responses obtained for each metabolite standard
446dissolved in solvent and in plasma at the same concentration
447level were compared with assess the matrix effects (MEs).
448Matrix effects were negligible for almost all compounds
449quantified (ME: 75–125%), with the exception of those
450metabolites not successfully extracted by using each of the
451three extraction methods assayed. Among polyphenol spe-
452cies, only flavan-3-ols (ME: 60–70% for PPT, 40–60% for
453Ostro®) and anthocyanins (ME: 40–70%) showed lower ME
454percentages. Furthermore, some very polar metabolites
Table 2 Validation parameters for diet-related metabolites with
authentic standards (n= 256) using the three extraction methods
optimized: solid phase extraction (Oasis® HLB), hybrid PPT, and SPE-
mediated removal of phospholipids (Ostro®), and protein
precipitation (PPT).
Oasis® HLB Ostro® PPT
Recovery
80–120% (53.9%) 80–120% (75.8%) 80–120% (81.6%)
60–80% (12.1%) 60–80% (12.5%) 60–80% (12.1%)
40–60% (6.6%) 40–60% (7.4%) 40–60% (5.1%)
<40% (25.4%) <40% (3.5%) <40% (1.2%)
>120% (2.0%) >120% (0.8%)
Matrix effect
75–125% (62.1%) 75–125% (80.1%) 75–125% (80.5%)
40–75% (11.7%) 40–75% (13.3%) 40–75% (12.9%)
<40% (26.2%) <40% (4.3%) <40% (1.5%)
>125% (2.3%) >125% (5.1%)
Limit of Quantification
<1 μg L−1 (11.0%) <1 μg L−1 (10.3%) <1 μg L−1 (10.2%)
1–10 μg L−1 (30.5%) 1–10 μg L−1 (32.7%) 1–10 μg L−1 (32.5%)








>100 μg L−1 (10.0%) >100 μg L−1 (12.4%) >100 μg L−1 (11.8%)
Intraday precision
<15% (99.0%) <15% (98.4%) <15% (98.8%)
15–20% (1.0%) 15–20% (1.6%) 15–20% (1.2%)
Interday precision
<15% (91.5%) <15% (91.7%) <15% (86.7%)
15–20% (8.5%) 15–20% (8.3%) 15–20% (13.3%)
Results are summarized in ranges for each validation parameter
evaluated: recovery rates, matrix effects, limits of quantification, intra-
and inter-day precisions (in brackets, the percentage of metabolites
found in each range).










455 analyzed in the void volume of the chromatographic method
456 were also slightly affected by ion suppression or ion
457 enhancement effects (ME: 60–70% and 125–140%,
458 respectively). Therefore, this shows that calibration curves
459 prepared in solvent can be used for plasma quantification
460without the need for a matrix-matched calibration, thereby
461considerably simplifying the analytical workflow.
462The method sensitivity was estimated by calculating the
463limits of quantification (LOQs) in spiked plasma samples
464for each metabolite. For polyphenolic metabolites, lower
465LOQs were generally obtained by applying HLB, followed
Fig. 1 Heat maps representing the recovery rates for dietary
metabolites with authentic standards validated using the three
extraction methods: solid phase extraction (Oasis® HLB), hybrid
PPT and SPE-mediated removal of phospholipids (Ostro®) and
protein precipitation (PPT). Information about abbreviations of
metabolite names can be found in Table S1.










466 by PPT and finally Ostro®. These were below 50 μg L−1
467 (0.5–5 μmol L−1) for most compounds (with the exception
468 of some phenolic acids) and in the range 0.1–10 μg L−1
469 (0.01–1 μmol L−1) for less polar species. Higher sensitivity
470 was obtained for metabolites analyzed under positive
471 polarity, with LOQs not surpassing 10 μg L−1 (0.1–1 μmol
472 L−1) for almost any of the compounds. Finally, instrumental
473 precision was shown to be reproducible over a minimum
474 period of three days, with intra- and inter-day precisions
475 below 15% for most metabolites, except for those with
476 higher LOQs, which were in the range 15–20%.
477 To sum up, it is noteworthy that the three extraction
478 methods optimized here have their own strengths and
479 weaknesses, with complementary analytical performance.
480 Protein precipitation stands out as the most suitable
481 extraction method for comprehensive metabolomics fin-
482 gerprinting. On the other hand, SPE-based procedures could
483 also be of great interest for analyzing specific polyphenol
484 classes (e.g., Oasis® HLB for phase II metabolites of iso-
485 flavones, Ostro® for flavonoid aglycones). In general, PPT
486 could be considered the gold-standard extraction method
487 given its broad analytical coverage. Furthermore, the tech-
488 nical simplicity and cost-efficiency of this protocol facilitate
489 its implementation in large-scale epidemiological studies.
490 As a counterpart, the application of SPE-based procedures
491 would be recommended in studies with a particular interest
492 in those polyphenol classes previously described, or as a
493 complement to PPT.
494 Validation of putative biomarkers
495 The PPT-based method previously optimized was applied to
496 plasma samples from a clinical trial (NCT03101436) with
497 the aim of testing its suitability for detecting dietary meta-
498 bolites in samples obtained from free-living subjects, where
499 these metabolites are usually found at low concentrations.
500 Furthermore, we also analyzed samples collected after a
501 one-month intervention with a Mediterranean diet supple-
502 mented with red wine as a case study to demonstrate the
503 utility of plasmatic metabolites as markers of specific food
504 intake.
505 Some microbiota-derived metabolites were regularly
506 detected in more than 80% of the plasma samples analyzed
507 from free-living subjects, including phenolic acids (around
508 15% of the total number of metabolites assayed),
509 hydroxyphenyl-valerolactones (e.g., 5-(3′,4′-dihydrox-
510 yphenyl)-γ-valerolactone) and enterolignans (e.g., enter-
511 olactone), which were predominantly found in the form of
512 sulfate conjugates. Similarly, methylxanthines, fatty acids,
513 and amino acid derivatives were also quantified in most of
514 these samples. In contrast, the detection rate of the rest of
515 metabolites assayed was much lower, which is indicative of
516 their higher specificity as food-intake biomarkers. Thus, the
517consumption of particular foods was reflected in the
518detection of specific metabolites classes, e.g., flavanones
519were associated with citrus intake (phase II derivatives of
520naringenin and hesperitin), isoflavones with soy (phase II
521derivatives of daidzein and genistein), stilbenes with red
522wine (phase II derivatives of resveratrol and microbiota-
523derived dihydroresveratrol), and glucosinolates with cruci-
524ferous vegetables (sulforaphane N-acetylcysteine). In a
525second validation step, the methodology was applied to
526plasma samples from subjects adhered to a Mediterranean
527diet supplemented with red wine. Statistical analysis evi-
528denced a significant increase in plasmatic levels of cis-
529resveratrol 4′-sulfate, dihydroresveratrol 3-sulfate, and ethyl
530sulfate, which are known biomarkers of red wine intake,
531after this long-term intervention period (Table 1) [27]. This,
532therefore, demonstrates the potential of the metabolomics
533platform developed here to quantify important aspects of the
534human diet, although future studies are needed to investi-
535gate other food groups.
536Comparison with other metabolomics platforms
537In general, the methodology optimized in the present work
538provided a similar analytical performance to that shown by
539other validated methods based on targeted nutrimetabo-
540lomic analysis of plasma/serum samples found in literature
541[28–30]. However, most of these previously published
542methods provide biased analytical coverage towards spe-
543cific biomarker classes, which makes the application of
544several complementary analyses mandatory in order to
545obtain a comprehensive overview of the food metabolome.
546Conversely, the metabolomics approach developed here
547allows the simultaneous quantitation of 450 food-related
548metabolites and microbiota derivatives in a single and short
549run, thereby minimizing costs and the consumption of
550valuable biological samples. Furthermore, this multi-
551targeted metabolomics method represents an excellent
552complement to other platforms usually employed in the
553metabolomics research field (e.g., Metabolon, Biocrates),
554which are mainly focused on the endogenous metabolome.
555Conclusions
556Metabolomics nowadays plays a prominent role in nutrition
557epidemiology for deciphering the association between
558nutrition and health. However, various authors have
559emphasized in recent years that one of the major challenges
560currently faced by nutrimetabolomics researchers is the
561need for novel methods for large-scale quantitative meta-
562bolomics to allow for cross-cohort comparisons and the
563pooling of data [6]. The present work clearly demonstrates
564the crucial importance of the extraction method for










565 analyzing the circulating food and microbiota-derived
566 metabolome in plasma/serum samples. We have optimized
567 three complementary extraction procedures based on PPT,
568 SPE, and hybrid PPT with SPE-mediated removal of
569 phospholipids, each one having their own strengths and
570 weaknesses. In general, PPT provides the most compre-
571 hensive metabolomic fingerprints, although SPE-based
572 protocols could also be of interest in studies focused on
573 specific polyphenol metabolites. The combination of these
574 novel extraction methods with a multi-targeted UHPLC-
575 MS/MS platform enables the simultaneous detection and
576 quantitation of 450 dietary metabolites in very short-run
577 times and using low volumes of biological sample, which
578 facilitates its application to epidemiological studies. Fur-
579 thermore, the use of simple and high-throughput extraction
580 and analytical methods considerably minimizes the use of
581 chemicals, and consequently costs. This methodology was
582 tested in plasma samples collected from free-living subjects
583 and after a one-month intervention with a Mediterranean
584 diet supplemented with red wine, demonstrating its utility in
585 the clinical practice.
586 Another research gap in nutrimetabolomics is the lack of
587 robust validation studies of putative food intake biomarkers
588 [31], which could be overcome by applying the method
589 optimized here. Therefore, future studies are needed to test
590 this methodology in acute/long-term controlled food inter-
591 vention trials with the aim of checking the frequency of
592 detection and kinetics of these food-related metabolites,
593 especially considering inter-individual variability factors,
594 and assessing their correlation with food intake. Evaluation
595 of the strengths and weaknesses of using plasma or urine
596 matrices for analyzing food intake biomarkers is also of
597 critical importance.
598 Acknowledgements This work has received funding from the Spanish
599 Ministry of Economy and Competitiveness (MINECO, PCIN-2015-
600 229, PCIN-2015-238, PCIN-2017-076) under the umbrella of the
601 European Joint Programming Initiative “A Healthy Diet for a Healthy
602 Life” (JPI HDHL, http://www.healthydietforhealthylife.eu), the
603 CIBERFES and CIBEROBN (co-funded by the FEDER Program from
604 EU), and from the Generalitat de Catalunya’s Agency AGAUR
605 (2017SGR1546). RGD thanks “Juan de la Cierva” program MINECO
606 (FJCI-2015-26590) and CAL the ICREA Academia award 2018.
607 Authors thank to Paul Needs and Paul Kroon (Quadram Institute
608 Bioscience) for kindly providing in-house synthesized standards.
609 Compliance with ethical standards
610 Conflict of interest xxx.Q5
611 Publisher’s note Springer Nature remains neutral with regard to
612 jurisdictional claims in published maps and institutional affiliations.
613References
6141. Ulaszewska MM, Weinert CH, Trimigno A, Portmann R, Andres
615Lacueva C, Badertscher R, et al. Nutrimetabolomics: an inte-
616grative action for metabolomic analyses in human nutritional
617studies. Mol Nutr Food Res. 2019;63:e1800384.
6182. Garcia-Aloy M, Andres-Lacueva C. Food intake biomarkers for
619increasing the efficiency of dietary pattern assessment through the
620use of metabolomics: unforeseen research requirements for
621addressing current gaps. J Agric Food Chem. 2018;66:5–7.
6223. Heianza Y, Qi L. Gene-diet interaction and precision nutrition in
623obesity. Int J Mol Sci. 2017;18:787.
6244. Drabsch T, Holzapfel C. A scientific perspective of personalised
625gene-based dietary recommendations for weight management.
626Nutrients. 2019;11:617.
6275. González-Peña D, Brennan L. Recent advances in the application
628of metabolomics for nutrition and health. Annu Rev Food Sci
629Technol. 2019;10:479–519.
6306. Brennan L, Hu FB. Metabolomics-based dietary biomarkers in
631nutritional epidemiology-Current status and future opportunities.
632Mol Nutr Food Res. 2019;63:e1701064.
6337. Dragsted LO, Gao Q, Scalbert A, Vergères G, Kolehmainen M,
634Manach C, et al. Validation of biomarkers of food intake - critical
635assessment of candidate biomarkers. Genes Nutr. 2018;13:14.
6368. Scalbert A, Brennan L, Manach C, Andres-Lacueva C, Dragsted
637LO, Draper J, et al. The food metabolome: a window over dietary
638exposure. Am J Clin Nutr. 2014;99:1286–308.
6399. Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van
640Ommen B. Metabolomics in human nutrition: opportunities and
641challenges. Am J Clin Nutr. 2005;82:497–503.
64210. Crews H, Alink G, Andersen R, Braesco V, Holst B, Maiani G,
643et al. A critical assessment of some biomarker approaches linked
644with dietary intake. Br J Nutr. 2001;86:S5–35.
64511. Shafaei A, Croft K, Hodgson J, Boyce MC. Simultaneous quan-
646titative analysis of polyphenolic compounds in human plasma by
647liquid chromatography tandem mass spectrometry. J Sep Sci.
6482019;42:2909–21.
64912. Achaintre D, Gicquiau A, Li L, Rinaldi S, Scalbert A. Quantifi-
650cation of 38 dietary polyphenols in plasma by differential isotope
651labelling and liquid chromatography electrospray ionization tan-
652dem mass spectrometry. J Chromatogr A. 2018;1558:50–58.
65313. de Oliveira DM, Pinto CB, Sampaio GR, Yonekura L, Catharino
654RR, Bastos DH. Development and validation of methods for the
655extraction of phenolic acids from plasma, urine, and liver and
656analysis by UPLC-MS. J Agric Food Chem. 2013;61:6113–21.
65714. Pereira-Caro G, Ordóñez JL, Ludwig I, Gaillet S, Mena P, Del Rio
658D, et al. Development and validation of an UHPLC-HRMS pro-
659tocol for the analysis of flavan-3-ol metabolites and catabolites in
660urine, plasma and feces of rats fed a red wine proanthocyanidin
661extract. Food Chem. 2018;252:49–60.
66215. Svilar L, Martin JC, Defoort C, Paut C, Tourniaire F, Brochot A.
663Quantification of trans-resveratrol and its metabolites in human
664plasma using ultra-high performance liquid chromatography tan-
665dem quadrupole-orbitrap mass spectrometry. J Chromatogr B
666Analyt Technol Biomed Life Sci. 2019;1104:119–29.
66716. Orozco-Solano MI, Ferreiro-Vera C, Priego-Capote F, Luque, de
668Castro MD. Automated method for determination of olive oil
669phenols and metabolites in human plasma and application in
670intervention studies. J Chromatogr A. 2012;1258:108–16.
67117. Palmnäs M, Brunius C, Shi L, Rostgaard-Hansen A, Torres NE,
672González-Domínguez R, et al. Perspective: Metabotyping-A
673potential personalized nutrition strategy for precision prevention
674of cardiometabolic disease. Adv Nutr. 2019 https://doi.org/10.
6751093/advances/nmz121.










676 18. González-Domínguez R, Urpi-Sarda M, Jáuregui O, Needs PW,
677 Kroon PA, Andrés-Lacueva C. Quantitative Dietary Fingerprint-
678 ing (QDF)-A Novel Tool for Comprehensive Dietary Assessment
679 Based on Urinary Nutrimetabolomics. J Agric Food Chem.
680 2020;68:1851–61.
681 19. Rotches-Ribalta M, Urpi-Sarda M, Llorach R, Boto-Ordoñez M,
682 Jauregui O, Chiva-Blanch G, et al. Gut and microbial resveratrol
683 metabolite profiling after moderate long-term consumption of red
684 wine versus dealcoholized red wine in humans by an optimized
685 ultra-high-pressure liquid chromatography tandem mass spectro-
686 metry method. J Chromatogr A. 2012;1265:105–13.
687 20. Tulipani S, Llorach R, Urpi-Sarda M, Andres-Lacueva C. Com-
688 parative analysis of sample preparation methods to handle the
689 complexity of the blood fluid metabolome: when less is more.
690 Anal Chem. 2013;85:341–8.
691 21. Food and Drug Administration (FDA), US Department of Health
692 and Human Services. Bioanalytical Method Validation. Guidance
693 for Industry. 2001.Q6
694 22. Carmical J, Brown S. The impact of phospholipids and phos-
695 pholipid removal on bioanalytical method performance. Biomed
696 Chromatogr. 2016;30:710–20.
697 23. Khymenets O, Rabassa M, Rodríguez-Palmero M, Rivero-Urgell
698 M, Urpi-Sarda M, Tulipani S, et al. Dietary epicatechin is avail-
699 able to breastfed infants through human breast milk in the form of
700 host and microbial metabolites. J Agric Food Chem.
701 2016;64:5354–60.
702 24. Ajila CM, Brar SK, Verma M, Tyagi RD, Godbout S, Valéro JR.
703 Extraction and analysis of polyphenols: recent trends. Crit Rev
704 Biotechnol. 2011;31:227–49.
705 25. Muñoz-González I, Sánchez-Patán F, Jiménez-Girón A, Cueva C,
706 Monagas M, Martín-Álvarez PJ, et al. Evaluation of SPE as
707preparative technique for the analysis of phenolic metabolites in
708human feces. Food Anal Methods. 2014;7:844–53.
70926. Fernandes I, Faria A, de Freitas V, Calhau C, Mateus N. Multiple-
710approach studies to assess anthocyanin bioavailability. Phytochem
711Rev. 2015;14:899–919.
71227. Castellano-Escuder P, González-Domínguez R, Wishart DS,
713Andrés-Lacueva C, Sánchez-Pla A FOBI: An ontology to repre-
714sent food intake data and associate it with metabolomic data.
715Database. 2020. In press. Q7
71628. Feliciano RP, Mecha E, Bronze MR, Rodriguez-Mateos A.
717Development and validation of a high-throughput micro solid-
718phase extraction method coupled with ultra-high-performance
719liquid chromatography-quadrupole time-of-flight mass spectro-
720metry for rapid identification and quantification of phenolic
721metabolites in human plasma and urine. J Chromatogr A.
7222016;1464:21–31.
72329. Gasperotti M, Masuero D, Guella G, Mattivi F, Vrhovsek U.
724Development of a targeted method for twenty-three metabolites
725related to polyphenol gut microbial metabolism in biological
726samples, using SPE and UHPLC-ESI-MS/MS. Talanta.
7272014;128:221–30.
72830. Marmet C, Actis-Goretta L, Renouf M, Giuffrida F. Quantification
729of phenolic acids and their methylates, glucuronides, sulfates and
730lactones metabolites in human plasma by LC-MS/MS after oral
731ingestion of soluble coffee. J Pharm Biomed Anal.
7322014;88:617–25.
73331. Maruvada P, Lampe JW, Wishart DS, Barupal D, Chester DN,
734Dodd D, et al. Perspective: Dietary biomarkers of intake and
735exposure-exploration with omics approaches. Adv Nutr.
7362020;11:200–15.
Quantifying the human diet in the crosstalk between nutrition and health by multi-targeted metabolomics. . .
